Fig. 2

Risk curves and survival curves for immune-related lncRNAs signature and radiomics signature. A The distribution of risk scores, survival status and immune-related lncRNAs expression for immune-related lncRNAs in GBM patients. B The distribution of risk scores, survival status and radiomics values for radiomics features in GBM patients. C Kaplan–Meier survival curves for high and low-risk groups based on median immune-related lncRNAs risk score (log-rank test P < 0.05). D Kaplan–Meier survival curves for high and low-risk groups based on median radiomics risk score (log-rank test P < 0.05)